Genentech and Biogen Idec, Inc. (Massachusetts) Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Copenhagen, Denmark; May 17, 2013 Genmab A/S (OMX: GEN) announced today that Genentech and Biogen Idec have…

---

FDA Accepts Biogen Idec, Inc. (Massachusetts)???s Biologics License Application for First Long-Lasting Factor VIII Therapy for Hemophilia A

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) announced today that the U.S. Food and Drug Administration (FDA) has accepted the companys Biologics License Application (BLA) for the market…

---

Isis Pharmaceuticals, Inc. Earns $3.5 Million From Biogen Idec, Inc. (California)

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!CARLSBAD, Calif., May 9, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that…

---

UPDATE 3-Biogen profit beats estimates, raises 2013 forecast

April 25 (Reuters) - Biogen Idec Inc reported higher-than-expected first quarter profit on Thursday and raised its full year forecasts, and the U.S. biotechnology said it sees its new drug Tecfidera b…

---